Therefore, it is believed that abnormal activation of the VHL-HIF-α signaling pathway plays an essentially important role in ccRCC carcinogenesis, and that the signaling molecules comprising this pathway would be potential candidates for molecular-targeted chemotherapy for ccRCC patients. Here, VHL is linked to nonpapillary renal cell carcinoma.